A Mechanism To Explain the Selection of the Hepatitis e Antigen-Negative Mutant during Chronic Hepatitis B Virus Infection
Authors:
- 1 February 2009
- journal article
- research article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 83 (3) , 1379-1392
Abstract
Hepatitis B virus (HBV) expresses two structural forms of the nucleoprotein, the intracellular nucleocapsid (hepatitis core antigen [HBcAg]) and the secreted nonparticulate form (hepatitis e antigen [HBeAg]). The aim of this study was to evaluate the ability of HBcAg- and HBeAg-specific genetic immunogens to induce HBc/HBeAg-specific CD4+/CD8+T-cell immune responses and the potential to induce liver injury in HBV-transgenic (Tg) mice. Both the HBcAg- and HBeAg-specific plasmids primed comparable immune responses. Both CD4+and CD8+T cells were important for priming/effector functions of HBc/HBeAg-specific cytotoxic T-lymphocyte (CTL) responses. However, a unique two-step immunization protocol was necessary to elicit maximal CTL priming. Genetic vaccination did not prime CTLs in HBe- or HBc/HBeAg-dbl-Tg mice but elicited a weak CTL response in HBcAg-Tg mice. When HBc/HBeAg-specific CTLs were adoptively transferred into HBc-, HBe-, and HBc/HBeAg-dbl-Tg mice, the durations of the liver injury and inflammation were significantly greater in HBeAg-Tg recipient mice than in HBcAg-Tg mice. Importantly, liver injury in HBc/HBeAg-dbl-Tg mice was similar to the injury observed in HBeAg-Tg mice. Loss of HBeAg synthesis commonly occurs during chronic HBV infection; however, the mechanism of selection of HBeAg-negative variants is unknown. The finding that hepatocytes expressing wild-type HBV (containing both HBcAg and HBeAg) are more susceptible to CTL-mediated clearance than hepatocytes expressing only HBcAg suggest that the HBeAg-negative variant may have a selective advantage over wild-type HBV within the livers of patients with chronic infection during an immune response and may represent a CTL escape mutant.Keywords
This publication has 62 references indexed in Scilit:
- Emergence and takeover of precore-stop mutant prior to exacerbation of e antigen-negative chronic hepatitis B after withdrawal of lamivudine therapyJournal of Medical Virology, 2006
- Immune Tolerance Split between Hepatitis B Virus Precore and Core ProteinsJournal of Virology, 2005
- Exploring the Biological Basis of Hepatitis B E Antigen in Hepatitis B Virus InfectionHepatology, 2003
- Intracellular Inactivation of the Hepatitis B Virus by Cytotoxic T LymphocytesImmunity, 1996
- Hepatitis B Virus ImmunopathogenesisAnnual Review of Immunology, 1995
- Hepatitis B virus precore mutant infection is associated with severe recurrent disease after liver transplantationHepatology, 1995
- Detection of precore hepatitis B virus mutants in asymptomatic HBsAg-positive family membersHepatology, 1994
- Coinfection study of precore mutant and wild-type hepatitis B-like virus in ducklingsHepatology, 1994
- Rapid “tea-bag” peptide synthesis using 9-fluorenylmethoxycarbonyl (Fmoc) protected amino acids applied for antigenic mapping of viral proteinsImmunology Letters, 1991
- Cross-resistance to the transplantation of syngeneic Friend, Moloney, and Rauscher virus-induced tumorsTransplantation, 1968